genOway S.A.
ALGEN.PA
Get informed when a big investor buys or sells
+ FollowMarket Cap$27.52M
Close$
Share Statistics
| Market cap | $27.52 Million |
|---|---|
| Enterprise Value | $43.38 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.07 |
| Beta | 0.37 |
| Outstanding Shares | 12,338,528 |
Return
| Return on Equity | -3.80% |
|---|---|
| Return on Assets | -1.82% |
| Return on Invested Capital | -10.81% |
Valuation & Multiples
| P/E Ratio | -13.35 |
|---|---|
| PEG | 0.64 |
| Price to Sales | 0.73 |
| Price to Book Ratio | 2.2 |
| Enterprise Value to Revenue | 1.07 |
| Enterprise Value to EBIT | -11.12 |
| Enterprise Value to Net Income | -53 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.74 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About genOway S.A.
157 employees
CEO: Alexandre Fraichard genOway S.A. is a global biotechnology enterprise that specializes in the creation, production, commercialization, and distribution of custom genetically engineered mouse, rat, and cell line models. The company develops bespoke mouse mod...